Considerations on Safety Concerns About Citalopram Prescribing

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mayo Clinic proceedings 2012-11, Vol.87 (11), p.1042-1045
Hauptverfasser:	Sheeler, Robert D., MD, Ackerman, Michael J., MD, PhD, Richelson, Elliott, MD, Nelson, Thomas K., MD, Staab, Jeffrey P., MD, Tangalos, Eric G., MD, Dieser, Lisa M., PharmD, RPh, Cunningham, Julie L., PharmD, RPh
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressive Agents, Second-Generation - adverse effects Antidepressive Agents, Second-Generation - therapeutic use Citalopram Citalopram - adverse effects Citalopram - therapeutic use Complications and side effects Depression - drug therapy Dosage and administration Dose-Response Relationship, Drug Drug Administration Schedule Drug Approval Drug Monitoring Heart Conduction System - drug effects Humans Internal Medicine Labeling Laws, regulations and rules Long QT Syndrome - chemically induced Long QT Syndrome - prevention & control Practice Guidelines as Topic Practice Patterns, Physicians' - standards Prescription writing Safety and security measures Safety Management - standards Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!